Correlation of Kidney Injury Molecule-1 and Nephrin Levels in Iraqi Patients with Diabetic Nephropathy
DOI:
https://doi.org/10.54133/ajms.v5i.167Keywords:
T2DM, Diabetic nephropathy, KIM-1, Nephrin, Renal functionAbstract
Background: Diabetic nephropathy is characterized by persistent microalbuminuria and metabolic changes that decline renal functions. Researchers have been prompted to explore new biomarkers such as KIM-1 and nephrin that may enhance the identification of disease. Objective: To Evaluate biomarker levels of kidney injury molculre-1 (KIM-1) concentration and nephrin as early and sensitive markers of nephropathy in type 2 diabetic patients. Method: One hundred T2DM patients were included in a cross-sectional study at the specialized center for endocrinology and diabetes, Baghdad. The first group includes 50 diabetic nephropathy (DN) patients, and the second group includes 50 T2DM patients without DN. Biochemical and clinical parameters were reported for participants, and serum and urine levels of KIM-1 and nephrin were analyzed by Enzyme-linked immunosorbent assay. Results: The study showed a significant increase in serum and urinary levels of KIM-1 and nephrin in DN patients compared to the control group. Serum nephrin is positively correlated with urinary nephrin, serum creatinine, ACR ratio, serum and urine KIM-1, and negatively correlated with the estimated glomerular filtration rate. Urinary nephrin was positively correlated with urinary albumin/creatinine ratio, KIM-1 level in both serum and urine, and negatively correlated with estimated glomerular filtration rate. Conclusion: KIM-1 and nephrin are specific and sensitive indicators of early-stage diabetic nephropathy-associated renal damage.
Downloads
References
Salih BH, Ali SH, Allehibi KI. Serum aldosterone levels in patients with diabetic nephropathy in relation to vascular calcification. Iraqi J Pharm Sci. 2019;28(1):53-63. doi: 10.31351/vol28iss1pp53-63. DOI: https://doi.org/10.31351/vol28iss1pp53-63
Yonus SS, AlKataan MAA. Mitochondrial copies number and some renal function biomarkers in type 2 diabetes mellitus on metformin. Iraqi J Pharm Sci. 2022;31(2):33-38. doi: 10.31351/vol31iss2pp33-38. DOI: https://doi.org/10.31351/vol31iss2pp33-38
Hussein AM, Ali SH, Rahma AM, Al-Shami AA. Anemia in diabetic patients without microalbuminuria; in relation to type of diabetes, glycemic control, and hs-CRP levels. Al-Nahrain J Sci. 2010;13(3):110-119. doi: 10.22401/JNUS.13.3.19. DOI: https://doi.org/10.22401/JNUS.13.3.19
Salman O, Merdaw MA, Almaliky AA. A Novel single nucleotide polymorphism of interleukin-10 gene is linked to type 2 diabetes mellitus in Iraqi patients with toxoplasmosis. Iraqi J Pharm Sci. 2022;31(Suppl.):1-8. doi: 10.31351/vol31issSuppl.pp1-8. DOI: https://doi.org/10.31351/vol31issSuppl.pp1-8
Crasto W, Patel V, Davies MJ, Khunti K. Prevention of microvascular complications of diabetes. Endocrinol Metab Clin. 2021;50(3):431-455. doi: 10.1016/j.ecl.2021.05.005. DOI: https://doi.org/10.1016/j.ecl.2021.05.005
Mohammed MM, Hadi RA, Salman IN. Potential positive effects using coenzyme Q10 supplement as adjuvant therapy to gabapentin for managing diabetic neuropathy. Iraqi J Pharm Sci. 2022;31(2):177-183. doi: 10.31351/vol31iss2pp177-183. DOI: https://doi.org/10.31351/vol31iss2pp177-183
Jung CY, Yoo TH. Pathophysiologic mechanisms and potential biomarkers in diabetic kidney disease. Diabetes Merab J. 2022;46(2):181-197. doi: 10.4093/dmj.2021.0329. DOI: https://doi.org/10.4093/dmj.2021.0329
Kostovska I, Tosheska-Trajkovska K, Topuzovska S, Cekovska S, Spasovski G, Kostovski O, et al. Urinary nephrin is earlier, more sensitive and specific marker of diabetic nephropathy than microalbuminuria. J Med Biochem. 2020;39(1):83-90. doi: 10.2478/jomb-2019-0026. DOI: https://doi.org/10.2478/jomb-2019-0026
Gohda T, Kamei N, Koshida T, Kubota M, Tanaka K, Yamashita Y, et al. Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney disease. J Diabetes Investig. 2020;11(2):435-440. doi: 10.1111/jdi.13139. DOI: https://doi.org/10.1111/jdi.13139
Weil JE, Lemley KV, Mason CC, Yee B, Jones LI, Blouch K, et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy. Kidney Int. 2012;82(9):1010. doi: 10.1038/ki.2012.234. DOI: https://doi.org/10.1038/ki.2012.234
Santoro D, Torreggiani M, Pellicanò V, Cernaro V, Messina RM, Longhitano E, et al. Kidney Biopsy in Type 2 Diabetic Patients: Critical Reflections on Present Indications and Diagnostic Alternatives. Int J Mol Sci. 2021;22(11):5425. doi: 10.3390/ijms22115425. DOI: https://doi.org/10.3390/ijms22115425
Hamid GS, Allawi AA, Ghudhaib KK. Correlation of pentosidine with kidney diseases in Iraqi patients with diabetic nephropathy. Iraqi J Sci. 2021;62(10):3436-3442. doi: 10.24996/ijs.2021.62.10.2. DOI: https://doi.org/10.24996/ijs.2021.62.10.2
Tofte N, Lindhardt M, Adamova K, Bakker SJL, Beige J, Beulens JWJ, et al. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomized placebo-controlled trial. Lancet Diabetes Endocrinol. 2020;8(4):301-312. doi: 10.1016/S2213-8587(20)30026-7. DOI: https://doi.org/10.1016/S2213-8587(20)30026-7
Lee TH, Chen JJ, Cheng CT, Chang CH. Does artificial intelligence make clinical decision better? A review of artificial intelligence and machine learning in acute kidney injury prediction. Healthcare (Basel). 2021;9(12):1662. doi: 10.3390/healthcare9121662. DOI: https://doi.org/10.3390/healthcare9121662
Jim B, Ghanta M, Qipo A, Fan Y, Chuang PY, Cohen HW, et al. Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study. PLoS One. 2012;7(5):e36041. doi: 10.1371/journal.pone.0036041. DOI: https://doi.org/10.1371/journal.pone.0036041
Mahmood AR. Estimation of oxidative stress and some trace elements in Iraqi men patients with type 2 diabetes mellitus. Iraqi J Pharm Sci. 2016;25(1):17-22. doi: 10.31351/vol25iss1pp17-22. DOI: https://doi.org/10.31351/vol25iss1pp17-22
Mesfine BB, Vojisavljevic D, Kapoor R, Watson D, Kandasamy Y, Rudd D. Urinary nephrin-a potential marker of early glomerular injury: a systematic review and meta-analysis. J Nephrol. 2023. doi: 10.1007/s40620-023-01585-0. DOI: https://doi.org/10.1007/s40620-023-01585-0
Doublier S, Salvidio G, Lupia E, Ruotsalainen V, Verzola D, Deferrari G, et al. Nephrin expression is reduced in human diabetic nephropathy: Evidence for a distinct role for glycated albumin and angiotensin II. Diabetes. 2003;52(4):1023-1030. doi: 10.2337/diabetes.52.4.1023. DOI: https://doi.org/10.2337/diabetes.52.4.1023
Williams ME. Diabetic nephropathy: the proteinuria hypothesis. Am J Nephrol. 2005;25(2):77-94. doi: 10.1159/000084286. DOI: https://doi.org/10.1159/000084286
Son GH, Kwon JY, Lee S, Park J, Kim YJ, Yun B, et al. Comparison of serum and urinary nephrin levels between normal pregnancies and severe preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2013;166(2):139-144. doi: 10.1016/j.ejogrb.2012.10.011. DOI: https://doi.org/10.1016/j.ejogrb.2012.10.011
Sabbisetti VS, Waikar SS, Antoine DJ, Smiles A, Wang C, Ravisankar A, et al. Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. J Am Soc Nephrol. 2014;25(10):2177–2186. doi: 10.1681/ASN.2013070758. DOI: https://doi.org/10.1681/ASN.2013070758
Salih RKM, Al-Gharawi AM, Al-Lehibi KI. The correlation between hyperglycemia and rheumatoid factor in type 2 diabetic patients in Al-Rusafa Area, Baghdad. Iraqi J Pharm Sci. 2012;21(1):105-111. DOI: https://doi.org/10.31351/vol21iss1pp105-111
Sutton TA, Fisher CJ, Molitoris BA. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int. 2002;62(5):1539-1549. doi: 10.1046/j.1523-1755.2002.00631.x. DOI: https://doi.org/10.1046/j.1523-1755.2002.00631.x
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Published by Al-Rafidain University College. This is an open access journal issued under the CC BY-NC-SA 4.0 license (https://creativecommons.org/licenses/by-nc-sa/4.0/).
